CVS plans to separate retail pharmacies from insurance and pharmacy-benefit businesses

CVS Health announced plans to create two publicly traded companies: one containing retail pharmacies and community healthcare, and another retaining health insurance, pharmacy services and care delivery. CVS expects to complete the separation in the first half of 2028 through a transaction intended to be tax-free to the company and its shareholders. It remains a plan. ^[1][2]

Insurer Aetna and Caremark would stay together. Caremark is a pharmacy-benefit manager: it administers prescription-drug coverage for health plans, including negotiating payment terms with pharmacies and drugmakers. The separation changes CVS’s long-running strategy of combining pharmacies, insurance and healthcare services, which included buying Aetna for roughly $78 billion in 2018.^[2][3]

Separate management teams would be able to set their own spending priorities, ending the need for one parent company to balance store investment against insurance and pharmacy-benefit needs. CVS expects greater focus to create value and says both companies should generate strong free cash flow—the cash left after operating expenses and capital spending. Those are company expectations; the payoff depends on whether operational improvements cover separation expenses and the cost of supporting shared functions independently.^[1]

The initial market response showed investors had yet to endorse that value proposition. One same-day report put CVS shares down 12% despite better-than-expected earnings, while health-insurance peers Elevance and Cigna rose 4% and 3%, respectively. That share-price divergence does not itself establish that competitors have won customers or business.^[4]

Impact

What to watch next

• The first half of 2028 is CVS’s expected completion window. Closing on schedule with the intended tax-free treatment would test its ability to turn the standalone-business plan into an operating reality.^[1]